Michael B. Lesser
2 Papers
Michael B. Lesser is an academic researcher. The author has contributed to research in topics: Internal medicine & Cardiomyopathy. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study.
Philip R. Fox,Bruce W. Keene,Kenneth E. Lamb,Karsten A. Schober,Valérie Chetboul,Virginia Luis Fuentes,Gerhard Wess,Jessie Rose Payne,Daniel F. Hogan,Alison A. Motsinger-Reif,Jens Häggström,Emilie Trehiou-Sechi,Deborah M. Fine-Ferreira,Reid K. Nakamura,Pamela M. Lee,Manreet K. Singh,Wendy A. Ware,Jonathan A. Abbott,Geoffrey Culshaw,Sabine Riesen,M. Borgarelli,Michael B. Lesser,Nicole Van Israël,Etienne Côté,John E. Rush,Barret J. Bulmer,Roberto A. Santilli,Andrea Vollmar,Maribeth J. Bossbaly,Nadine Quick,Claudio Bussadori,Janice M. Bright,Amara H. Estrada,Dan G. Ohad,María Josefa Fernández del Palacio,Jenifer Lunney Brayley,Denise Saretta Schwartz,Christina M. Bové,Sonya G. Gordon,Seung Woo Jung,Paola Brambilla,N. Sydney Moïse,Christopher D. Stauthammer,Rebecca L. Stepien,C. Quintavalla,Christophe Amberger,Ferenc Manczur,Yong Wei Hung,Remo G. Lobetti,Marie de Swarte,A. Tamborini,Carmel T. Mooney,Mark A. Oyama,Andrey Komolov,Yoko Fujii,Romain Pariaut,Masami Uechi,Victoria Yukie Tachika Ohara +57 more
TL;DR: Preclinical HCM/HOCM is a global health problem of cats that carries substantial risk for CHF, ATE, and cardiovascular death, and this finding underscores the need to identify therapies and monitoring strategies that decrease morbidity and mortality.
Long-term incidence and risk of noncardiovascular and all-cause mortality in apparently healthy cats and cats with preclinical hypertrophic cardiomyopathy.
Philip R. Fox,Bruce W. Keene,Kenneth E. Lamb,Karsten E. Schober,Valérie Chetboul,Virginia Luis Fuentes,Jessie Rose Payne,Gerhard Wess,Daniel F. Hogan,Jonathan A. Abbott,Jens Häggström,Geoffrey Culshaw,Deborah M. Fine-Ferreira,Etienne Côté,Emilie Trehiou-Sechi,Alison A. Motsinger-Reif,Reid K. Nakamura,Manreet K. Singh,Wendy A. Ware,Sabine Riesen,M. Borgarelli,John E. Rush,Andrea Vollmar,Michael B. Lesser,Nicole Van Israël,Pamela Ming-Show Lee,Barret J. Bulmer,Roberto A. Santilli,Maribeth J. Bossbaly,Nadine Quick,Claudio Bussadori,Janice M. Bright,Amara H. Estrada,Dan G. Ohad,Maria Josefa Fernadez del Palacio,Jenifer Lunney Brayley,Denise Saretta Schwartz,Sonya G. Gordon,Seung Woo Jung,Christina M. Bové,Paola Brambilla,N. Sydney Moïse,Christopher D. Stauthammer,C. Quintavalla,Ferenc Manczur,Rebecca L. Stepien,Carmel T. Mooney,Yong-Wei Hung,Remo G. Lobetti,A. Tamborini,Mark A. Oyama,Audrey Komolov,Yoko Fujii,Romain Pariaut,Masami Uechi,Victoria Yukie Tachika Ohara +55 more
TL;DR: All‐cause mortality was significantly greater in pHCM cats due to disease burden contributed by increased cardiovascular death superimposed upon noncardiovascular death.